97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,630 Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05117749
(ClinicalTrials.gov)
May 202321/10/2021Saffron and Ulcerative ColitisThe Effect of Saffron in Patients With Ulcerative Colitis: A Randomized Double-blind Clinical TrialUlcerative ColitisDrug: Saffron 100;Drug: Saffron 50;Drug: PlaceboShiraz University of Medical SciencesNULLNot yet recruiting18 Years80 YearsAll60Phase 2NULL
2NCT05715099
(ClinicalTrials.gov)
March 30, 202319/1/2023Saffron as Anti Inflammatory In Patients With Inflammatory Bowel DiseaseEfficacy of Nutritional Saffron Supplement as an Anti-inflammatory Agent in Egyptian Patients With Inflammatory Bowel DiseaseUlcerative ColitisDrug: Saffron;Drug: PlaceboMinia UniversityNULLNot yet recruiting18 Years60 YearsAll90Phase 4Egypt
3NCT04749576
(ClinicalTrials.gov)
December 15, 20209/12/2020Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel DiseaseEfficacy of Nutritional Saffron Supplement As An Anti Inflammatory Agent In Patients With Inflammatory Bowel DiseaseUlcerative ColitisDietary Supplement: saffron supplement for IBDHoward UniversityNULLRecruiting18 Years80 YearsAll100N/AUnited States